Tools · Private company · Boulder, CO, US

Orbit Genomics, Inc.

Track this companyFree. Adds Orbit Genomics, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials0None registered

Pipeline programs0None found yet

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

NIH awards2

Development of a lung cancer subtyping diagnosticFiscal year 2025 · $999.6KNIH RePORTER 5R44CA291262-02 · fetched Nov 12, 2026
Development of a lung cancer subtyping diagnosticFiscal year 2024 · $999.6KNIH RePORTER 1R44CA291262-01A1 · fetched Nov 12, 2026